Expanded access provides an additional treatment option for those with chronic migraine.- AbbVie is dedicated to people living with ...
Candesartan seems to be effective and well tolerated in preventing episodic migraine in adults, a phase 2 trial shows.
The 2024 McDonald criteria improve early MS diagnosis with higher sensitivity and accuracy, but lower specificity in real-world settings.
Zacks Small Cap Research on MSN
TNXP: Tonmya™ Approved by FDA…
TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonmya™ Approved by the FDA On August 15, 2025, Tonix Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback